A genetic risk score to personalize prostate cancer screening, applied to population data

por Huynh-Le, Minh-Phuong, Fan, Chun Chieh, Karunamuni, Roshan, Walsh, Eleanor I., Turner, Emma L., Lane, J. Athene, Martin, Richard M., Neal, David E., Donovan, Jenny L., Hamdy, Freddie C., Parsons, J. Kellogg, Eeles, Rosalind A., Easton, Douglas F., Kote-Jarai, ZSofia, Al Olama, Ali Amin, Garcia, Sara Benlloch, Muir, Kenneth, Gronberg, Henrik, Wiklund, Fredrik, Aly, Markus, Schleutker, Johanna, Sipeky, Csilla, Tammela, Teuvo LJ, Nordestgaard, Børge G., Key, Timothy J., Travis, Ruth C., Pharoah, Paul D. P., Pashayan, Nora, Khaw, Kay-Tee, Thibodeau, Stephen N., McDonnell, Shannon K., Schaid, Daniel J., Maier, Christiane, Vogel, Walther, Luedeke, Manuel, Herkommer, Kathleen, Kibel, Adam S., Cybulski, Cezary, Wokolorczyk, Dominika, Kluzniak, Wojciech, Cannon-Albright, Lisa A., Brenner, Hermann, Schöttker, Ben, Holleczek, Bernd, Park, Jong Y., Sellers, Thomas A., Lin, Hui-Yi, Slavov, Chavdar Kroumov, Kaneva, Radka P., Mitev, Vanio I., Batra, Jyotsna, Clements, Judith A., Spurdle, Amanda B., Teixeira, Manuel R., Paulo, Paula, Maia, Sofia, Pandha, Hardev, Michael, Agnieszka, Mills, Ian G., Andreassen, Ole A., Dale, Anders M., Seibert, Tyler M.
Publicado en Cancer Epidemiol Biomarkers Prev (2020)